Label: CALYPXO HP PAIN RELIEF- methyl salicylate, menthol cream
- NDC Code(s): 76420-999-01
- Packager: Asclemed USA, Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated October 16, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active Ingredients
- Purpose
- Uses
-
Warning
- For external use only.
- Avoid contact with eyes and mucous membranes.
Do not
- bandage tightly or cover treated areas.
- use with heating pad.
- apply to open wounds or damages skin.
- A mild burning sensation may occur.
- If severe burning sensation occurs, discontinue use immediately.
- If symptoms persist for more than seven days, discontinue use and consult physician.
- Directions
- Additional Information
- Other Ingredients
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
CALYPXO HP PAIN RELIEF
methyl salicylate, menthol creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:76420-999 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength METHYL SALICYLATE (UNII: LAV5U5022Y) (SALICYLIC ACID - UNII:O414PZ4LPZ) METHYL SALICYLATE 15 g in 100 g MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL 10 g in 100 g Inactive Ingredients Ingredient Name Strength CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO) ALOE VERA LEAF (UNII: ZY81Z83H0X) WATER (UNII: 059QF0KO0R) CETYL ALCOHOL (UNII: 936JST6JCN) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS) POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) PHENOXYETHANOL (UNII: HIE492ZZ3T) SODIUM LAURYL SULFATE (UNII: 368GB5141J) TROLAMINE (UNII: 9O3K93S3TK) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:76420-999-01 113 g in 1 BOTTLE; Type 0: Not a Combination Product 12/10/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M017 12/10/2020 Labeler - Asclemed USA, Inc (059888437)